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Compliance by patients to prescribed treatment regimens can be considered as the interface between effective 
therapy and effective disease management. Compliance can be affected by the nature of the relationship between the 
practitioner and the patient, and their attitudes towards each other. It has also been suggested that practitioner 
behaviour can influence patient behaviour and health status. However, each individual patient is influenced in his or 
her attitudes, and reactions to disease and its management, by a wide variety of patient-related factors. These 
include psychological variables such as mood, beliefs, and the knowledge, motivation and ability of the patient. 
Social factors may also play a role: these include age, marital and socioeconomic status and level of education. 
Results from a range of studies in patients with pulmonary or other diseases show that the psychosocial 
determinants of compliance are only poorly understood, and suggest that compliance cannot be predicted from 
patients’ health status and that social factors are weak indicators only. Furthermore, it appears from available data 
that patients’ beliefs about health issues are not as useful as indicators of likely compliance as was previously 
believed. 
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Introduction patients to understand why patients fail to follow medical 
advice. 
The use of a regular inhaled anti-inflammatory drug with a 
bronchodilator provides effective relief of symptoms for 
many asthmatics. However, despite the availability of a 
large number of well-tolerated treatments, non-compliance 
with asthma (and other) medications remains a problem 
(1). Studies available suggest that, although some patients 
do indeed manage their disease well, many do not take 
medication as prescribed (2-4). As non-compliance with 
treatment is a cause of mortality and morbidity in asthma 
(5,6), it is in the interests of both practitioners and their 
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A variety of different factors that relate directly to 
patients and their personal characteristics and back- 
grounds can influence compliance with asthma therapy, 
and many of these can be applied to compliance with 
therapy for other chronic diseases. These factors are 
complex and involve psychological, social and medical 
issues, all of which may alter patients’ perceptions of the 
benefits of compliance with their recommended treatment 
regimen. Social and cultural factors, such as socioeco- 
nomic status, level of education and health belief issues 
may also influence the ways in which patients perceive 
their treatments, and may affect compliance with them. 
Attempts have been made to determine levels of com- 
pliance in patients with asthma and other diseases, and 
while accurate determination of compliance is difficult, the 
measurement of variables that affect compliance can be 
even more difficult. In most studies, compliance is 
reported, rather than objectively measured. The propor- 
tion of compliers in most studies appears to be low 
(approximately 50%). Notwithstanding these difficulties 
and complications, there are a number of studies of 
interest that have been conducted in a variety of 
therapeutic areas. 
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Compliance and the doctor-patient 
relationship 
A report published by the Royal Pharmaceutical Society of 
Great Britain’s working party on medicine-taking has 
recommended that ‘concordance’ should replace the term 
‘compliance’ (7). This change in terminology reflects the 
change in the doctor-patient relationship. In modern 
society the doctor-patient relationship should be one that 
is based less on trust and more on openness and respect. 
The price for this loss of dependence on the doctor will be 
greater responsibility, in the doctor’s case for the quality of 
the evidence, diagnosis, treatment and explanation, and in 
the patient’s case for the consequences of his/her choices. 
At a consultation, for example, the patient should convey 
his/her health beliefs, the doctor should enable this to 
happen and use his/her expertise to make a diagnosis and to 
recommend the most appropriate intervention. Thus, the 
intention is to form a therapeutic alliance, which should 
allow the patient to make as informed a choice as possible 
about the diagnosis and treatment; the most important 
determinations, in terms of patient behaviour, are those 
that are made by the patients themselves. 
Patient-related factors affecting 
compliance with asthma therapy 
PSYCHOLOGICAL FACTORS 
Increasing interest has been shown in recent years in the 
relationship between psychological and social factors and 
asthma, and these issues should be taken into account when 
plans for the management of patients are made. Psycholo- 
gical factors that can influence compliance with asthma and 
other treatments include cognitive impairment, especially in 
the elderly in whom memory or concentration may be 
affected, and a loss of the patient’s capacity to understand 
the need for treatment. Psychopathology associated with 
the illness may also be involved, and may take the form of 
clinical depression, anxiety, denial or fatalism. Further- 
more, poor interpersonal skills may affect the ability of the 
patient to interact effectively with the clinician and/or 
others who are key to achieving effective therapy. Func- 
tional illiteracy may also be seen, which affects the patient’s 
ability to read and follow simple instructions. 
Dew et al. (8) identified compliance problems in a group 
of 101 patients who had undergone heart and lung 
transplantation and were followed for 1 yr. This may be 
considered surprising in the light of the critical nature of the 
procedure involved; however, the investigators found that 
anger and hostility were four times as likely to be identified 
in patients with poor compliance than in those who 
complied with their treatment regimen. Such reactions 
may be related to patients’ postoperative experiences and 
such factors as their perceptions of their own personal 
difficulties and lack of support from their families. 
Few data are available to show the effect of psychological 
factors on the compliance of patients with asthma. However, 
in a prospective study of 102 such patients, psychological 
assessment was performed using the Hospital Anxiety and 
Depression Scale and the Inventory of Interpersonal 
Problems, and compliance with inhaled medication was 
recorded using an electronic device, over a 12-week period 
(9). Of those patients who completed the study, 51% were 
defined as non-compliant (< 70% of the prescribed dose, or 
doses omitted for at least 1 week). Non-compliant patients 
had a significantly higher mean score for depression than 
compliant patients (4.7 V.Y. 3.2, P<O.O5), and the depression 
score correlated with non-attendance at follow-up clinics. 
There was no significant difference in anxiety score between 
non-compliant and compliant patients (Fig. 1). Anxiety can 
have both positive and negative effects on compliance, as 
anxious patients may be highly motivated to take medication 
exactly as prescribed or be overwhelmed and unable to follow 
the prescriber’s instructions. 
PATIENT MOTIVATION, ABILITY AND 
BELIEFS 
When individuals are faced with health advice from their 
doctor or another healthcare professional they will interpret 
and evaluate this advice and decide whether it should be 
incorporated into their behaviour. Patients make this 
evaluation in the light of their beliefs about the illness 
and the treatment. Thus, within the concordance model, 
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FIG. 1. Hospital Anxiety and Depression Scores (HADS) 
for compliant and non-compliant patients in patients with 
asthma. x * test showed no significant difference between 
compliers and non-compliers for anxiety, but P-e 0.05 
for depression (9). 0: compliant; H: non-compliant. 
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there are two main areas the clinician can focus on in an 
attempt to achieve optimal patient compliance with 
therapy: firstly, the degree of motivation of the patient 
(which will predominantly affect intentional non-compli- 
ance), and secondly, the ability of the patient (which will 
affect unintentional non-compliance). In order to increase a 
patient’s motivation for treatment, the clinician needs to 
focus on the patient’s beliefs, and to improve a patient’s 
ability the clinician needs to focus on a patient’s skills 
(Fig. 2). 
Compliance is thought to be heavily influenced by the 
knowledge and attitudes of the patient. These factors have 
been encompassed in a number of different psychological 
models, the best known of which is Becker’s health belief 
model. (10). This model postulates that the likelihood of 
patients following a healthcare or treatment regimen is 
related to their motivation and incentive to do so. Two 
main beliefs held by patients about their medications have 
emerged: the necessity of the medication (i.e. necessary for 
present and future maintenance of health) and concern 
about the medication (arising from beliefs about potential 
negative effects, such as dependence). Patients with stronger 
beliefs about the necessity of the particular treatment are 
likely to have higher compliance, while those with stronger 
concerns are likely to have lower compliance with treat- 
ment. Thus, patients engage in a risk-benefit analysis, 
balancing the necessity with the concerns of the medication, 
and non-compliance may be a logical attempt to moderate 
the perceived risks by taking less. It is important that the 
patients’ perceived risks are not based on mistaken beliefs 
about the dangers of the medication, and this is where the 
doctor must allow the patient to make as informed a choice 
as possible. In addition, a patient’s understanding of his or 
her disease is likely to be influenced by education and 
socioeconomic status. These are classified as social rather 
than psychological factors, and are therefore discussed 
later. 
All factors relate to the degree of motivation and 
ability that the patient develops during treatment, and 
there is therefore a need for a combined approach to 
intervention that will be effective on the different causal 
factors. Thus, increasing concordance by focusing on 
beliefs and correcting misconceptions about treatment 
d 
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FIG. 2. A simple model relating the factors that influence 
motivation and ability to intentional and unintentional 
compliance. Note the association of patient factors 
(highlighted) with patient motivation and ability. 
might increase motivation to take medication, and increas- 
ing the convenience of a regimen might improve skills and 
hence ability to comply. These factors are also inter-related, 
as a patient who is unable to use a treatment will become 
demotivated, and one who thinks a treatment is unneces- 
sary may not develop the skills to use the medication. 
Notwithstanding the above, data of considerable interest 
are available from the southern U.S.A. which cast doubt on 
the hypothesis that health beliefs influence adherence to 
good health-related behaviour. Martin and Paniucci (11) 
studied 20 health beliefs (including dental visits, wearing of 
car seat belts, abstinence from tobacco and alcohol and 
checking of blood pressure) in Black women aged over 65 
years who were recruited through local Baptist churches. As 
might be expected, the women studied believed that all 
these beneficial practices were important, and assigned to 
them a mean overall importance score of 9.36 (range 8.4 to 
10.0) out of 10. However, self-reporting of adherence to 
these practices resulted in an overall adherence rate that 
was somewhat lower (85%) with a much wider range (28 to 
100%). Most importantly, the investigators found no 
evidence of any correlation between health beliefs and an 
individual’s adherence to those beliefs (r = -0.01; P = 
0.9). This indicates that although patients may be aware of 
measures that are beneficial to their health, not all will 
comply with these measures. 
MOTIVATION AND THE STAGES OF 
CHANGE MODEL FOR COMPLIANCE 
The Stages of Change Model is a device for examining the 
structure of change associated with both self-mediated and 
treatment-facilitated modification of addictive and other 
problem behaviours (12,13). It integrates motivational and 
behavioural aspects and recognizes the process character 
and temporal dimension of behaviour change. It also shows 
how these changes occur and which mechanisms are 
important (14). However, it is important to note that none 
of these studies have used this model to test patient 
outcomes, such as health status and healthcare use, while 
few, if any, have focused on chronic illness. The main use of 
the model has been exercise compliance or participation. 
The model consists of five ordered categories that describe 
motivational readiness to change a problem behaviour. 
These five stages of change are: 
Precontemplation: there is no intention to change 
behaviour in the foreseeable future. Many individuals at 
this stage are unaware or under aware of their problems, or 
are not yet ready to deal with a threatening illness and are 
not willing to adopt relevant strategies. 
Contemplation: at this stage, the individual is aware that 
a problem exists and is thinking about overcoming it, but 
has yet to make a commitment to take action. 
Preparation: intention and behavioural criteria are 
combined at this stage. Individuals intend to take action 
(usually within 30 days), and may have taken a first step 
towards action in the past year. 
Action: this is where individuals modify their behaviour, 
experiences or environment to overcome their problems, 
and involves the most overt behavioural changes. This stage 
involves expenditure of the most time and energy. 
Maintenance: individuals work to prevent relapse and to 
consolidate gains made during the action stage. Main- 
tenance is an active stage that can last from 6 months to 
5 yr; for some behaviours, maintenance can be considered 
to last for life. 
Transition between the stages of change is affected by a 
set of independent variables known as the processes of 
change. Knowledge of these processes, together with the 
characteristics of the individual and the current stage of 
change, should help healthcare professionals decide how to 
most effectively motivate the patient, and improve com- 
pliance with therapeutic regimens. 
SOCIAL FACTORS 
Various factors such as age, marital and socioeconomic 
status and level of education should be considered when 
promoting compliance. However, before each of these is 
examined in detail, none of these factors will guarantee that 
an individual will comply, hence it is recommended that 
clinicians treat every patient as a non-complier to ensure 
that all receive adequate education. High levels of 
unemployment, single-parenthood and the culture of 
poverty associated with low socioeconomic status can 
seriously affect the ability and motivation of an individual 
or family to manage chronic illness. Families that lack the 
social and structural support of financial resources and the 
presence of two parents to share household and childcare 
responsibilities carry significant additional burdens com- 
pared with others who possess these advantages. Compli- 
ance with treatment regimens may also be influenced by the 
patient’s level of literacy. Financial, personal and structural 
barriers to compliance, such as difficulty in attending the 
clinic for repeat visits and prescriptions, and concomitant 
problems and stresses (e.g. poor housing and low levels of 
social support) that make compliance with therapy a low 
priority for the patient, are all likely to combine to cause 
considerable problems for healthcare professionals who are 
trying to provide effective treatment. 
Schrott et al. (15) investigated 2763 post-menopausal 
women with heart disease in the U.S.A. who were receiving 
medication to improve their serum lipid profiles (defined as 
the achievement of 1988 and 1993 Adult Treatment Panel 
goals of a serum LDL-cholesterol level of below 3.4 mmol 
1-i or 2.6 mmol l-‘, respectively). Although 47% of 
participants were taking lipid-lowering medication, 63% 
did not meet the 1988 treatment goal and 91% did not meet 
that for 1993. The status of being unmarried (adjusted odds 
ratio [OR] 0.47; P = 0.002) and education to graduate level 
(OR 0.69; P = 0.02), were shown by multiple logistic 
regression to be associated with failure to achieve the 1998 
LDL-cholesterol target. Women who smoked (OR 1.90; 
P-C 0.001) drank alcohol (OR 1.10; P = 0.01) or who were 
African Americans (OR 2.03; P-C 0.001) were found to be 
more likely to fail to comply with lipid-lowering medica- 
tion, whereas older women (OR 0.75; P = 0.008) and those 
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who had never married (OR 0.36; P = 0.02) were more 
likely to comply. 
Increasing age and education to a higher level appeared 
to predict more consistent compliance in a study in patients 
requiring anti-arrhythmic therapy (16). Compliance over 
1 yr was assessed by self-reporting and tablet counting in 
930 of an original cohort of 1816 enrolled patients. 
However, unlike Schrott et al. (15), these investigators 
found that consistent compliance was predicted by the 
presence of a spouse, which indicates that the support 
provided by a partner may be a significant social factor 
affecting compliance with therapy. Good general and 
mental health and low levels of stress were also found 
(perhaps not surprisingly) to predict more consistent 
compliance over a I-yr period. 
Compliance data are also available from two large 
studies in patients with chronic obstructive pulmonary 
disease (COPD). In one trial, the compliance (based on 
average time of nebulizer use each day) of 985 patients on 
home nebulizer therapy was assessed by questionnaire (17). 
The best social predictors (by logistic regression) of good 
compliance were White race (almost certainly a socio- 
economic factor) and married status (adjusted OR 2.30 and 
1.49, respectively). Other good predictors were increased 
age, history of higher education and stable lifestyle. 
Negative factors were also identified in these patients: these 
included smoking and drinking habits. However, although 
statistically significant, numerical differences between 
groups tended to be only small, which may call the clinical 
significance of these differences into question (Fig. 3). 
Two-year follow-up data (analysed by multiple logistic 
regression) are available from the Lung Health Study, a 
double-blind, multicentre, randomized controlled trial of 
smoking intervention and bronchodilator therapy in which 
3923 participants had their compliance measured by self- 
reporting and weighing of metered-dose inhaler canisters. 
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FIG. 3. Compliance with long-term nebulizer therapy for 
COPD in the IPPB trial. Differences between groups 
(compliant and non-compliant patients) for race, marital 
status and smoking status. Note small numerical 
differences between groups, although P = 0.001 for all 
these variables (17). 0: compliant (n=498); n : non- 
compliant (n = 487). 
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One-year results (with adjusted ORs) for self-reported 
compliance confirmed by canister weights indicated that 
compliance was associated with marital status (1.461), age 
(1.055), race (1.859), shortness of breath (0.906) confine- 
ment to bed with a respiratory infection (0.788), days 
hospitalized (0.728) and poor respiratory function (0.863) 
(18). Moreover, the level of compliance was reported to 
have initially improved with the use of a structured 
programme, but to have declined over 2 yr. The self- 
reported rate of inhaler use exactly as prescribed declined 
from 52% at the first 4-month follow-up visit to 43% at 
year 1 and 38% at year 2. 
There appear, to date, to be few studies evaluating 
predictors of compliance with treatment in patients with 
asthma. Preliminary results of a study in 45 female and 43 
male patients are available (19), however, in which 
compliance with metered-dose inhaler therapy was mea- 
sured with questionnaire answers and the Inhaler Adher- 
ence Scale (IAS), which ranges from 0 (compliant) to 6 
(non-compliant). Compliance in this trial was found to be 
better in older patients (I = -0.24; PC 0.05) and those 
with lower peak flow rates (r = 0.25; P < 0.05). IAS scores 
were better (i.e. lower and hence more compliant) in female 
than male patients (Fig. 4), and occupational profile 
significantly influenced the IAS score with unemployed 
patients having a better score than professionals (Fig. 4). 
Conversely, level of education and number of work days 
missed because of asthma did not correlate with IAS scores. 
COMPLIANCE PROBLEMS IN THE 
ELDERLY 
It should be noted that, although increasing age was 
associated with improved compliance in all the trials 
reported above, problems can be encountered in elderly 
patients who may be taking a variety of medications for a 
number of medical conditions. Social isolation, often 
encountered in the elderly, is a significant predictor for a 
number of chronic health problems, disability and pre- 
mature death (20). In addition to auditory and visual 
impairment, elderly patients may also have cognitive 
difficulties (including forgetfulness or dementia) which 
may make the understanding and following of treatment 
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regimens difficult. Many elderly patients also care for 
elderly partners who may have chronic health problems of 
their own (which complicates the management of their own 
conditions), and may have diseases such as arthritis that 
make the use of metered-dose inhalers difficult or impos- 
sible. 
Quality of life 
As described earlier, Lurie et al. (19) found no correlation 
between quality of life and level of compliance in patients 
with asthma. This is surprising when viewed in the light of 
the simple hypothesis that the attainment of better health 
through effective treatment should lead to positive reinfor- 
cement of good compliance behaviours. Clinical papers that 
include comparisons of quality of life and compliance are 
unfortunately few, but there are nevertheless some data 
available from trials in patients with pulmonary or other 
diseases. 
In general, compliance has not been shown to be related 
to quality of life or mood state, and only weakly related to 
disease severity, in a variety of studies. In a study in patients 
undergoing haemodialysis, compliance with treatment was 
found to be associated with severity of illness (as judged by 
attending clinicians), but not with Karnofsky performance 
status, level of social support or patients’ perceptions of 
illness (21). It should be noted that the Karnofsky scale 
measures a patient’s functional status, and is not a true 
quality-of-life measure; however, it may be argued that the 
use of markers such as this is made acceptable by the 
shortage of available data with which to investigate the 
present arguments. Results are also available from patients 
receiving immunosuppressive therapy after renal transplan- 
tation to show that compliance was unrelated to demo- 
graphic variables (apart from better compliance with 
prednisone treatment for men than women, which may be 
a sampling issue because of the small sample assessed in this 
study), graft function or Nottingham Health Profile (a 
generic measure of impaired health) (22). However, 
compliance in these patients increased significantly after 
episodes of transplant rejection, which may explain the 
observation that compliance was better for immunosup- 
pressive than for anti-hypertensive therapy (PC 0.0001). 
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FIG. 4. Inhaler Adherence Scale (IAS) scores for patient gender and occupation in 88 ambulatory patients with asthma. P-K 
0.05 between males and females; PC 0.0007 for differences between occupations (unemployed, non-active, students, 
professionals) (19). 
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TABLE 1. Compliance with anti-retroviral therapy in patients with AIDS (adapted with permission (23) [Carfax Publishing 
Ltd, Abingdon, U.K.] 
Variable 
Results P 
Compliant patients Non-compliant patients 
(n = 29) (n= 17) 
Age (years) 
Depression score (Beck Depression Inventory) 
Overall mood score (Profiles of Mood State score) 
Karnofsky score 
Coping 
Previous intravenous drug misuse (%) 
39 42 n.s. 
14.1 19.5 n.s. 
43 65 ns. 
87 92 n.s. 
8.2 11.6 0.03 
21 59 0.01 
Major predictors of compliance were described by 
Schron et al. (16) in a study in patients receiving anti- 
arrhythmic therapy. However, interpretation of the data 
from this study is complicated by the finding that patients 
with, a history of angina or myocardial infarction and those 
with poor physical function were likely to be good 
compliers. This appears to conflict with another observa- 
tion from these authors that patients with good general and 
mental health were more likely to adhere to treatment, and 
indicates that the relationship between health status and 
compliance is far from straightforward. However, results 
obtained by Singh et al. (23) were more concordant with 
those in other trials and indicated that depression (Beck 
Depression Inventory), overall mood (Profiles of Mood 
State scores) and Karnofsky scores did not correlate with 
compliance or non-compliance in patients with AIDS who 
were receiving anti-retroviral therapy (Table 1). Patients 
were assessed at baseline, and at 6 and 12 months, with 
those taking at least 80% of their medication being classed 
as compliant. The overall compliance rate was 63%, and 
the major predictor of non-compliance was a history of 
intravenous drug misuse. 
In the COPD trial of Turner et al. (17), there were no 
statistically significant differences between compliers and 
non-compliers in terms of generic quality of life (as assessed 
by the Sickness Impact Profile) and mood (as assessed by 
the Profile of Mood Status scores) (P = 0.8 and 0.5, 
respectively). The need for caution when analysing data 
derived from patients’ answers to questionnaires that relate 
to compliance were evident in this trial from the reasons 
patients gave for their use of nebulized therapy. Of the 
compliant patients, 82% said they adhered to their 
treatment because it made them feel better; however, as 
many as 67% of the non-compliant patients responded 
similarly. Reasons for missing nebulized therapy are less 
unexpected (Table 2) but the high numbers of non- 
compliant patients who felt too tired or busy to use their 
nebulized therapy concurs with the premise described 
earlier that patients apply value judgements to their 
treatments and are unlikely to adhere to the prescribed 
regimen if they perceive its benefits not to outweigh its 
inconvenience and other negative characteristics. 
Conclusions 
Clearly, there are very few assumptions that may be made 
on the basis of currently available evidence about the way 
in which a patient’s psychological and social background 
will affect their likelihood to comply with medication for 
asthma (or any other condition). Although it appears that 
the behaviour of practitioners can influence patients’ 
behaviour and therefore health outcomes (24,25), the 
effects of other factors are unclear. Each patient is uniquely 
shaped and affected by his or her background and 
psychological status, and may well respond to treatment 
instructions in a way that is entirely unexpected, as in cases 
where poor compliance is seen in patients with critical 
illnesses. Overall, it seems that there is still much to be 
learned about the psychosocial determinants of compliance 
in asthma. Although information gleaned from studies in 
patients with other diseases could be useful, data are 
currently too few and inconsistent to be able to draw solid 
conclusions, or to extrapolate from one disease state to 
another. Currently available results suggest that compliance 
cannot be predicted from a patient’s health status, that 
social factors are weak determinants, if at all useful, and 
that an understanding of patients’ beliefs may not be as 
useful as has been previously thought. Certainly, studies 
into the decision-making processes used by patients with 
asthma (and other conditions) are needed, and practitioners 
TABLE 2. Reasons given by patients for missing nebulized 
drug therapy in the IPPB study (17) 
Reason Percentage of patients P 
Compliant Non-compliant 
No effect on 
breathing 
Too tired 
Too busy 
21 42 0.001 
7 31 0.001 
20 45 0.001 
862 N. CLARK ETAL. 
should endeavour to relate to each patient as a unique 
individual. 
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